Get started
Author

Lucia Ribero

Observed names: L. Ribero, Ribero, Lucia
ORCID: 0000-0002-6460-5936
Observed ORCID: 0000-0002-6460-5936
OpenAlex ID: A5081697577
The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment
2025 · Luigi A. De Vitis, Gabriella Schivardi, et al. · International Journal of Gynecological Cancer · 22
Surgical site infection prevention bundle in gynecology oncology surgery: a key element in the implementation of an enhanced recovery after surgery (ERAS) program
2024 · Lucia Ribero, María Clara Santía, et al. · International Journal of Gynecological Cancer · 8
Surgical complexity and scope of procedures necessary after neoadjuvant chemotherapy for primary ovarian cancer
2025 · Chiara Ainio, Marina Rosanu, et al. · Gynecologic Oncology · 5
Predictors of recurrence in early-stage cervical cancer without adjuvant treatment after radical surgery
2025 · Giuseppe Caruso, Michela Gaiano, et al. · European Journal of Surgical Oncology · 5
Single-port robotic surgery in gynecologic oncology: feasibility and safety after 1 year of implementation
2026 · Lucia Ribero, Gabriella Schivardi, et al. · International Journal of Gynecological Cancer · 4
Para-aortic lymph node recurrence in surgically treated early-stage cervical cancer without para-aortic lymph node surgical staging
2024 · Tullio Golia D'Augè, Giuseppe Caruso, et al. · International Journal of Gynecological Cancer · 4
Defining surgical fitness in advanced ovarian cancer: a critical review of predictors, algorithms, and pre-habilitation
2026 · Lucia Ribero, Diletta Fumagalli, et al. · International Journal of Gynecological Cancer · 3
Is PORTEC-4a the tipping point in endometrial cancer management?
2025 · Ilaria Betella, Lucia Ribero · The Lancet Oncology · 3
Deep Learning for Decision Support in Ovarian Cancer Treatment Planning
2025 · Francesca Fati, Marina Rosanu, et al. · Research Square · 2
PDF
Impact of neoadjuvant chemotherapy on homologous recombination deficiency test results in patients with advanced high-grade serous ovarian cancer
2026 · Ilaria Betella, Diletta Fumagalli, et al. · International Journal of Gynecological Cancer · 1
Lymphadenectomy in early-stage ovarian cancer: is there still a role?
2026 · Giuseppe Caruso, Susanna Delfrati, et al. · International Journal of Gynecological Cancer · 1
Evaluating the feasibility of NGS-based germline genetic testing in ovarian carcinoma. the PERSONA-ovary trial.
2026 · Ilaria Betella, Emanuele Bonetti, et al. · International Journal of Gynecological Cancer · 1
Detection rate of sentinel lymph nodes in early-stage endometrial cancer according to age
2025 · A. Giudici, G. Schivardi, et al. · European Journal of Surgical Oncology · 1
Laparoscopic Repair of a Deep Cesarean Scar Defect Guided by Hysteroscopy: Surgical Technique
2022 · A.S. Naessens Aspiazu, G.O. Vietri, et al. · Journal of Minimally Invasive Gynecology · 1
Clinical implications of germline and somatic genetic testing in ovarian carcinoma: BRCA and beyond. The PERSONA-Ovary trial
2026 · Ilaria Betella, Emanuele Bonetti, et al. · Gynecologic Oncology
Evolution of treatment strategies for advanced epithelial ovarian cancer: a 16-year overview from a referral center
2026 · Lucia Ribero, Diletta Fumagalli, et al. · International Journal of Gynecological Cancer
Is the New Portec-4a/esgo-estro-esp-adapted Algorithm Prognostic in a Real-world Population?
2026 · Lucia Ribero, Gabriella Schivardi, et al. · International Journal of Gynecological Cancer
Early-stage No-specific Molecular Profile (nsmp) Endometrial Cancer: Clinicopathological and Molecular Predictors of Recurrence
2026 · Lucia Ribero, Diletta Fumagalli, et al. · International Journal of Gynecological Cancer
Predicting Response to Neoadjuvant Chemotherapy in Ovarian Cancer from CT Baseline Using Multi-Loss Deep Learning
2026 · Francesco Pastori, Francesca Fati, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
PDF
Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?
2026 · Chiara Ainio, Giuseppe Caruso, et al. · Gynecologic Oncology
Impact of indocyanine green fluorescence angiography on anastomotic leak in ovarian cancer cytoreductive surgery: a retrospective cohort study
2026 · Gabriella Schivardi, Lucia Ribero, et al. · International Journal of Gynecological Cancer
Three-Dimensional Deep Learning Prediction of Cytoreduction Outcome Using Preoperative CT Scans: A Preliminary Internal Validation Study
2026 · Roberto Veraldi, Marina N. Rosanu, et al. · International Journal of Gynecological Cancer
Evidence-Based Text-Conditioned 3D CT Synthesis for Ovarian Cancer
2026 · Panaccione, Francesca Pia, Lomurno, Eugenio, et al. · arXiv (Cornell University)
PDF
Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center
2026 · Susanna Delfrati, Giuseppe Caruso, et al. · International Journal of Gynecological Cancer
Surgical outcomes after primary and interval cytoreductive surgery in advanced epithelial ovarian cancer
2026 · Cristina Taliento, Lucia Ribero, et al. · International Journal of Gynecological Cancer
Works count: 44
Citation count: 61
H-index: 4
I10-index: 1
Year
Topic
Type